Ask AI
ProCE Banner Series

Plotting a Treatment Course for EGFR-Mutated NSCLC: Nursing Considerations and Skill-Based Training for Oncology Nurses and NPs

Register now for this expert-led, interactive live series to learn more about key nursing considerations in managing patients with EGFR-mutated NSCLC.

Who Should Attend

This activity has been designed to meet the educational needs of nurse practitioners, oncology nurses, and other healthcare professionals who care for patients with non-small-cell lung cancer.

Topics

Lung cancer

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners’ knowledge and competence in the nursing management of patients with non-small-cell lung cancer who are receiving or eligible for EGFR-targeted treatment. 

Target Audience
This activity has been designed to meet the educational needs of nurse practitioners, oncology nurses, and other healthcare professionals who care for patients with non-small-cell lung cancer. 

Learning Objectives
Upon completion of this event, participants should be able to:

  • Explain practical testing for the early detection and identification of actionable EGFR mutations, including interpreting results and implications for treatment planning
  • Differentiate the mechanisms of action of tyrosine kinase inhibitors, bispecific antibodies, and other EGFR-targeted agents approved for EGFR-mutated NSCLC
  • Provide supportive care for patients receiving EGFR-targeted treatment for EGFR-mutated NSCLC, taking into account patient-specific considerations and emphasizing strategies to improve outcomes and quality of life
  • Identify and manage treatment-related AEs associated with EGFR-targeted therapies in patients with EGFR-mutated NSCLC, utilizing evidence-based strategies to minimize patient discomfort and optimize therapeutic outcomes

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour, including 1.0 hour of pharmacotherapy credit.

ILNA Recertification Points
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points in the following ILNA subject areas:

  • Care Continuum (OCN, CBCN, CPHON, AOCNP)*
  • Oncology Nursing Practice (OCN)*
  • Symptom Management, Palliative Care, Supportive Care (OCN, CPHON, AOCNP)*
  • Treatment (OCN, CBCN, AOCNP, CPHON)*

Total Points: 1.0*

*Note that the course content applies to multiple subject areas across multiple credentials. The numerical value indicated above is the maximum number of points that can be claimed in each subject area.  The total amount of ILNA points claimed may not exceed the total amount of nursing continuing professional development (NCPD) awarded from this course.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC.

CCO 2022

Supporters

Supported by educational grants from AstraZeneca and Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

AstraZeneca

Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191